FOR INFORMATION CONTACT:

Spencer Sias (650) 424-5782

spencer.sias@varian.com

For Immediate Release:

Varian Imaging Components President Robert Kluge Announces Plans to Retire;

Varian CEO Dow Wilson Names Sunny Sanyal as Kluge’s Successor

PALO ALTO, Calif., December 16, 2013 – Varian Medical Systems (NYSE:VAR) today announced that Robert H. Kluge has announced his intention to retire as its Senior Vice President and President, Imaging Components Businesses effective February 7, 2014. Varian CEO Dow R. Wilson has named and the Board of Directors has appointed Sunny Sanyal, CEO of T-System, to succeed Kluge. Varian’s Imaging Components Businesses are comprised of the X-Ray Products and Security and Inspection Products businesses.

“Bob Kluge built Varian’s X-Ray Products revenues from $75 million in 1993 to $546 million at the end of fiscal 2013,” Wilson said. “We are indebted to Bob for his strategic vision, intelligent management, and consistent execution that have propelled Varian to a leadership position in the global imaging industry. He has set the stage for continued success and growth in our components businesses.

“Sunny Sanyal is an experienced leader who will work with our seasoned imaging components management team to expand and capitalize on the growth potential for these businesses,” Wilson said. “We look forward under Sunny’s leadership to building these businesses into a billion dollar platform for Varian.”

Sanyal, 49, will assume his position as Senior Vice President and President, Imaging Components Businesses on February 3, 2014. Prior to joining T-System, a privately-held company providing information technology solutions and services to hospitals and urgent care facilities, Sanyal was president of McKesson Provider Technologies, where he led the company to significant market expansion with its clinical IT solutions. He also worked for GE Healthcare, Accenture and IDX Systems.

“I am excited to be a part of Varian,” Sanyal said. “Bob and team have built a tremendous business for Varian. I look forward to working with the team to continue building these businesses through market expansion, continued innovation, and strong customer relationships.”

Sanyal has an MBA from Harvard Business School, an MS in Industrial Engineering from Louisiana State University, and a bachelor’s degree in Electrical Engineering from the University of Bombay.

-- more --

Varian Imaging Components President Robert Kluge Announces Plans to Retire; Page 2

Varian CEO Dow Wilson Names Sunny Sanyal as Kluge’s Successor

Kluge, 67, will retire but support the leadership transition in an advisory capacity as needed. “I have enjoyed building the X-ray Products business for Varian and I have been fortunate to have great relationships with our customers, Varian management, and the imaging components team,” said Kluge. “I expect this team will continue to excel and that these businesses will thrive under Sunny’s leadership.”

# # #

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,400 people who are located at manufacturing sites in North America, Europe, and China and 72 sales and support offices around the world. For more information, visit http://www.varian.com.

Forward-Looking Statements

Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the company’s future orders, revenues, backlog, or earnings growth; future financial results; the ability of the company’s technology and products to save lives; and any statements using the terms “will,” “continue,” “expect,” “set the stage,” “expand,” “look forward,” or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the company’s ability to effectively integrate new management; the company’s ability to retain the services of key personnel; the effect of global economic conditions; demand for the company’s products; the company’s ability to develop, commercialize, and deploy new products; the impact of competitive products and pricing; the potential loss of key distributors or partners; and the other risks listed from time to time in the company’s filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.